Bristol-Myers Squibb Co. (NYSE:BMY)

Prescription drugs

Major Pharma Short Interest Faces Significant Drop

The short interest data have been released for the August 15 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Medicine pills

Major Pharma Short Interest Slides

The short interest data have been released for the July 29 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
mind the gap

Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further

Last week's news from Bristol-Myers Squibb Co. (NYSE: BMY) about Opdivo in first line non-small cell lung cancer missing its primary endpoint absolutely crushed its shares. It is just usual to ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: BlackRock, Bristol-Myers, Level 3, NVIDIA, Monsanto, 21st Century Fox and More

Stocks were indicated to open marginally higher on Monday, even after hitting new highs last week. Investors are still looking for ways to make money, and they have proven over ...
Read Full Story »
analysis

Why Bristol-Myers Failure Is a Huge Win for Merck

Shares of Bristol-Myers Squibb Co. (NYSE: BMY) took a nosedive in Friday’s session following an update in its late-stage Checkmate trial. Unfortunately the results did not reach the primary endpoint, and ...
Read Full Story »
coins

Bristol-Myers Earnings Don’t Appear to Be Enough for Investors

Bristol-Myers Squibb Co. (NYSE: BMY) released its second-quarter earnings report before the markets opened on Thursday. The company posted $0.69 in earnings per share (EPS) on $4.87 billion in revenue, ...
Read Full Story »
Prescription drugs

Short Sellers Get Selective on Major Pharma

The short interest data have been released for the July 15 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Medicine pills

Top Analyst Thinks Big Pharmaceutical Stocks Will Outperform the Rest of 2016

Ever since the Hillary Clinton high drug price tweet in September of last year, the major pharmaceuticals and biotechs have struggled, and while performance has improved over the past quarter, ...
Read Full Story »
Prescription drugs

Short Sellers Run for Cover From Major Pharma

The short interest data have been released for the June 30 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Prescription drugs

How Major Pharma Is Faring After the Brexit

The broad markets are recovering in the wake of the Brexit and it really appears to be one big head fake. We are also realizing that the Brexit was a ...
Read Full Story »
Prescription Drugs, Pills

Short Sellers Increase Bets Against Major Pharmaceutical Stocks

The short interest data have been released for the June 15 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Medicine pills

Major Pharma Has Short Sellers on the Run

The short interest data have been released for the May 31 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
Medicine pills

How Credit Suisse Views Major Pharma After ASCO

The American Society of Clinical Oncology (ASCO) annual meeting is absolutely making waves in the pharmaceutical industry. As a result, analysts are giving their two cents on companies making presentations ...
Read Full Story »
Female patient on gurney

Merrill Lynch Picks ASCO Winners

The health care sector is descending on Chicago as the American Society of Clinical Oncology (ASCO) annual meeting nears. This meeting draws many companies and analysts alike, looking for the ...
Read Full Story »
Doctor, Health (pulse) copy

Key Movers to Look for Ahead of ASCO

The American Society of Clinical Oncology (ASCO) is in the process of gearing up for its annual meeting. At this meeting, cancer drug developers will share the results from their ...
Read Full Story »